Dr Tye-Din is a gastroenterologist with a clinical and research interest in Coeliac disease. He heads the Coeliac Research Lab at the Walter and Eliza Hall Institute, runs a Coeliac clinic at the Royal Melbourne Hospital and is an Honorary Research Fellow at the Murdoch Children’s Research Institute. His PhD employed feeding studies to characterise gluten immunity that underpinned development of a novel immunotherapy for Coeliac disease, Nexvax2.
His research interests include understanding the immune and genetic basis for coeliac disease and how gluten tolerance is lost, the role of the microbiome, understanding why the gluten-free diet can fail, and developing and testing novel diagnostics and treatments. He is on the editorial board of Alimentary Pharmacology and Therapeutics and consults for an industry partner (ImmusanT Inc.) who are leading the development of Nexvax2. Jason chairs the Medical Advisory Committee of Coeliac Australia and is involved in patient advocacy, clinical guideline development and medical education.
In todays talk, we covered a lot. There was so much about coeliac disease that I didn’t know, and so, I think a lot of people, medical professionals as well as individuals managing this disease, will find this episode really interesting and helpful.
So what did we cover?
We talked about
and...a whole lot more...
Please enjoy my conversation with Dr Jason Tye-Din